Preferred panel for diagnosing possible tick-borne disease (ie, Anaplasmosis or Ehrlichiosis) during the acute phase of the disease. If also investigating babesiosis, consider Tick-Borne Disease Panel by PCR, Blood (2008670).
Qualitative Polymerase Chain Reaction
New York DOH Approval Status
Lavender (EDTA) or Pink (K2EDTA).
Transport 1 mL whole blood. (Min: 0.6 mL)
Serum, plasma, and heparinized specimens.
Ambient: 24 hours; Refrigerated: 1 week; Frozen: 1 week
A negative result does not rule out the presence of PCR inhibitors in the patient specimen or test-specific nucleic acid in concentrations below the level of detection by this test.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
This test detects and speciates Anaplasma phagocytophilum; Ehrlichia chaffeensis; E. ewingii/E. canis; E. muris-like. The nucleic acid detected from E. ewingii and E. canis cannot be differentiated by this test. A result of "Detected" for E. ewingii/canis indicates the presence of either of these two organisms in the specimen.
87468; 87484; 87798 x2
|Component Test Code*||Component Chart Name||LOINC|
|2007863||Anaplasma phagocytophilum by PCR||30039-2|
|2007865||Ehrlichia chaffeensis by PCR||27994-3|
|2007867||Ehrlichia ewingii/canis by PCR||48865-0|
|2007869||Ehrlichia muris-like by PCR||48866-8|
- Anaplasma phagocytophilum
- E. canis
- E. muris-like; E. ewingii
- Ehrlichia chaffeensis